1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd
  6. News
  7. Summary
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD

(4519)
  Report
Delayed Japan Exchange  -  05/24 02:00:00 am EDT
3551.00 JPY   -1.72%
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
AQ
04/27CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Nikkei erases early gains as markets fret over Delta virus variant

06/29/2021 | 11:17pm EDT

TOKYO, June 30 (Reuters) - Japanese stocks erased early gains to trade flat on Wednesday, as investors held back from making big bets on concerns of the Delta variant of COVID-19 in Asia and amid a nine-month-old trend of a weak finish on the last trading of the month.

At midday, the Nikkei average was flat at 28,815.10, having erased early gains of 0.65%. The broader Topix edged up 0.03% at 1,949.97.

Shares initially took cues from an overnight rally in Wall Street, but investor-buying quickly succumbed to anxiety about the Japanese markets' peculiar pattern since September to fall on the last trade of the month.

Some market players think it could be due to month-end rebalancing by big investors, while others think it is just a coincidence.

"It's just an anomaly. But then again, a lot of people are talking about it, so it does have some effect on the psychology," Masato Kogure, group leader of trade execution at Tokai Tokyo Securities said.

The market flitted within a range, underperforming global shares as investors weigh the progress in vaccination rollout against a surge in domestic infections ahead of the Olympics next month.

Among big movers, Sugi Holding tumbled 7.8% after the drugstore chain operator's quarterly earnings fell short of market expectations.

Nitto Boseki slid 6.1% after one of its shareholders announced a plan to sell almost 1 million shares, or about 2% of the outstanding, of the textile company.

Shares of J. Front Retailing dropped 3.8% after the department store operator cut its profit outlook.

Chugai Pharmaceutical rose as much as 7.9% after it applied for regulatory approval in Japan of an antibody treatment for COVID-19.

Murata Manufacturing gained 3.1% after the company said it sees merit in lowering the minimum volume investors are able to trade in its shares while Ushio Inc jumped 12.7% after the lamp maker lifted its earnings outlook, doubling its net profit forecast for the current year through March. (Reporting by Hideyuki Sano; editing by Sherry Jacob-Phillips)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
CHUGAI PHARMACEUTICAL CO., LTD -1.72% 3551 Delayed Quote.-3.27%
J.FRONT RETAILING CO., LTD. -1.10% 990 Delayed Quote.-4.39%
MURATA MANUFACTURING CO., LTD -0.95% 8169 Delayed Quote.-9.94%
NIKKEI 225 -0.94% 26748.14 Real-time Quote.-6.22%
NITTO BOSEKI CO., LTD. -3.65% 2243 Delayed Quote.-20.95%
S&P 500 -1.40% 3926.73 Real-time Quote.-16.63%
SUGI HOLDINGS CO.,LTD. -1.51% 5230 Delayed Quote.-23.82%
TOPIX INDEX -0.86% 1878.26 Delayed Quote.-4.91%
USHIO INC. -2.18% 1664 Delayed Quote.-10.94%
All news about CHUGAI PHARMACEUTICAL CO., LTD
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
04/28Chugai Pharmaceutical Co., Ltd. - Notice of Completion of Disposal of Treasury Shares a..
AQ
04/27CHUGAI PHARMACEUTICAL : Notice of Completion of Disposal of Treasury Shares as Restricted ..
PU
04/26CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
04/26Chugai Pharmaceutical Co., Ltd. - Organizational and Personnel Changes
AQ
04/26Nikkei 225 Up 0.4% on Wall Street Cues, Softer Interest Rates, Oil Outlook
MT
04/26Chugai Pharmaceutical Logs 178% Surge in Q1 Net Income on Higher Sales
MT
04/25CHUGAI PHARMACEUTICAL : 1Q Results (Jan-Mar 2022)
PU
04/25Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces First Quarter Sales 20..
AQ
04/25CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Results for the..
PU
More news
Analyst Recommendations on CHUGAI PHARMACEUTICAL CO., LTD
More recommendations
Financials
Sales 2022 1 187 B 9 291 M 9 291 M
Net income 2022 343 B 2 682 M 2 682 M
Net cash 2022 604 B 4 727 M 4 727 M
P/E ratio 2022 17,0x
Yield 2022 2,19%
Capitalization 5 840 B 46 151 M 45 711 M
EV / Sales 2022 4,41x
EV / Sales 2023 4,91x
Nbr of Employees 7 664
Free-Float 37,8%
Chart CHUGAI PHARMACEUTICAL CO., LTD
Duration : Period :
Chugai Pharmaceutical Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHUGAI PHARMACEUTICAL CO., LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 3 551,00 JPY
Average target price 4 677,69 JPY
Spread / Average Target 31,7%
EPS Revisions
Managers and Directors
Tatsuro Kosaka Manager-Pharmaceutical Business Strategy Office
Osamu Okuda Manager-Life Cycle Management II
Itagaki Toshiaki CFO, Manager-Information Technology & Accounting
Hisafumi Okabe Senior Executive Officer & Head-Research
Junichi Nezu Executive Officer, GM-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHUGAI PHARMACEUTICAL CO., LTD-3.27%46 509
JOHNSON & JOHNSON4.89%472 179
PFIZER, INC.-10.45%296 704
ROCHE HOLDING AG-14.40%273 052
ELI LILLY AND COMPANY9.55%272 388
ABBVIE INC.9.33%261 585